Fritextsökning
Innehållstyper
-
Column: Why there cannot be a complete cure for cancer – but there is certainly another way!
"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.
-
The new Astra Zeneca CEO: “An incredibly exciting phase”
Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including...
-
Column: "Are we already living in the new normal?"
2020 felt like the year that we were building the house around us whilst moving into it at the same time.
-
Sweden and Denmark – this is how they choose their strategies
Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.
-
New study: Post-Covid symptoms are common even after mild Covid-19
According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...
-
Är ditt ERP tillräckligt skalbart för att hantera Life Science?
Ett flexibelt och skalbart affärssystem är viktigt inom alla branscher men extra viktigt inom Life Science, varför då?
-
Alert from the Swedish Medicines Agency: Many complications with gastric balloons
According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for ...
-
Svensk vaccinutvecklare får 24 miljoner av brittiskt forskningsprogram
Abera Bioscience får upp till motsvarande cirka 24 miljoner kronor i finansiering från ett brittiskt program inriktat på vacciner som ska stoppa epidemier i låg...
-
He is heading a new company for the development of Coegin’s cancer drug
The biotechnology company Coegin Pharma places the development of its drug candidate AVX420 in a newly formed company, Avexxin Oncology, based in Norway, and Jo...
-
Omvänt förvärv ska ta Flerie till börsen – ”Viktigt steg i bolagets plan”
Läkemedelsinvesteraren Flerie Invest tar en genväg till börsen genom ett omvänt förvärv av forskningsbolaget Index Pharmaceuticals.
-
Swedish breakthrough in Alzheimer’s: “We can finally present great data”
Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes ...
-
From spin-off to phase II
”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.
-
Webinar: Medtech quality and regulatory compliance
This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...
-
Newly discovered gene variant linked to protection against abdominal obesity
American researchers believe they have identified a rare gene mutation that protects against abdominal obesity and metabolic syndrome. The ambition is that the ...
-
The stomach medication that became the biggest blockbuster of the 1990s
The omeprazole molecule was synthesised as early as 1979, but it took many years before the then Astra had an approved pharmaceutical. Once this happened, a tab...
-
A green nursery for biotech rooted in the Scanian soil
Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...
-
Medivirs licenspartner avbryter cancerprogram
Medivirs amerikanska licenspartner Tango Therapeutics har beslutat att avbryta utvecklingen av cancerkandidaten TNG348.
-
Ny vd hos Index Pharmaceuticals
I januari 2023 får Index Pharmaceuticals en ny vd. Jenny Sundqvist efterträder Johan Giléus som varit tillförordnad vd sedan april i år.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...
-
Pfizer’s record year – topped the $100 billion mark
In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson...
-
Rovtidskriftsjägaren om sin ärkefiende: ”Ondskans imperium”
Han myntade begreppet rovtidskrifter och gjorde ett första försök att kartlägga deras utbredning. Nu berättar bibliotekarien Jeffrey Beall om konsekvenserna det...
-
The TFS family is growing
TFS HealthScience is a European based CRO company with broad expertise and experiences in the biotech and pharmaceutical sector. The company is growing and the ...
-
“We aim to be a start-up company with an academic spirit”
Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...
-
Oväntat stort mörkertal för TBE-infektioner – ”Vi blev väldigt överraskade”
En ny studie tyder på att infektioner av det fästingburna TBE-viruset är långt vanligare i Sverige än man hittills trott.